nAChR

Nicotinic acetylcholine receptor (nAChR) agonists, antagonists and modulators act on ligand-gated cation channels. Each receptor is a pentamer of subunits arranged around a central pore that opens when acetylcholine binds. A refined structure of the Torpedo receptor at 4 Å resolution, published in 2005, resolved its ligand-binding, membrane and cytoplasmic regions. Muscle-type receptors mediate neuromuscular transmission, while neuronal subtypes such as α7 and α4β2 are studied in attention, memory and nicotine dependence. Agonists include PNU 282987, which is selective for α7, and the partial agonist varenicline. PNU-120596, described in 2005, is a positive allosteric modulator of α7 that enhances acetylcholine-evoked currents. Vecuronium bromide, a neuromuscular blocking agent, acts on the muscle-type receptor.

Items 201-225 of 268

  • T761-0184
    Cat. No.
    A67685

    T761-0184

    T761-0184 is a potent antagonist of the alpha-7 nicotinic acetylcholine receptor (nAChR). This compound effectively inhibits nAChR activity, making it a valuable tool for studying neurotransmission and synaptic plasticity. It holds potential for research applications in neurological disorders and offers insights into the mechanisms underlying cholinergic signaling.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • PHA 568487
    Cat. No.
    A67687

    PHA 568487

    PHA 568487 is a selective agonist of the α-7 nicotinic acetylcholine receptor (α-7 nAchR). This compound demonstrates significant biological activity in reducing neuroinflammation and oxidative stress, making it valuable for research in neurodegenerative diseases and cognitive disorders. Its ability to rapidly penetrate the blood-brain barrier enhances its potential for therapeutic applications in central nervous system studies.

    10 mg
    $660.00
    50 mg
    $2,720.00
    All 2 sizes
  • Aristoquinoline
    Cat. No.
    A67688

    Aristoquinoline

    Aristoquinoline is a naturally occurring alkaloid derived from Aristotelia chilensis, functioning primarily as an inhibitor of the α3β4 nicotinic acetylcholine receptor (nAChR). This compound demonstrates significant biological activity by modulating neurotransmitter signaling, making it a valuable tool for research in neuropharmacology, particularly in studies related to addiction, cognitive function, and neurodegenerative diseases. Its specific inhibitory effect on nAChR presents opportunities for investigating the receptor's role in various physiological processes.

    Out of stock

    All 3 sizes
  • R-(+)-Cotinine
    Cat. No.
    A67689

    R-(+)-Cotinine

    Synonyms: (+)-Cotinine; (R)-Cotinine; (R)-NIH-10498

    R-(+)-Cotinine is a nicotine metabolite that primarily targets nicotinic acetylcholine receptors. It has been shown to enhance acetylcholine-evoked currents in human α7 nAChRs, indicating its potential role in modulating cholinergic neurotransmission. This compound is valuable for research applications focused on nicotine effects, signaling pathways, and receptor pharmacology.

    5 mg
    $215.00
    10 mg
    $285.00
    All 3 sizes
  • Sazetidine A hydrochloride
    Cat. No.
    A67690

    Sazetidine A hydrochloride

    Sazetidine A hydrochloride is a potent ligand that targets the α4β2 nicotinic acetylcholine receptor (nAChR). It exhibits high binding affinity and selectivity for this receptor subtype, making it a valuable tool in pharmacological research. Its properties may contribute to the development of therapies for conditions related to nicotinic receptor dysfunction. Additionally, Sazetidine A hydrochloride serves as an important compound in studies investigating the binding affinities of various nAChR analogs, enhancing the understanding of subtype selectivity among ligands.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • A 844606
    Cat. No.
    A67691

    A 844606

    A 844606 is a highly selective agonist of the α4β2 nicotinic acetylcholine receptor (nAChR), demonstrating potent activation of this target. Its significant biological activity makes it a valuable tool for investigating neurodegenerative and psychiatric conditions, including schizophrenia, Huntington's disease, Alzheimer's disease, and Parkinson's disease. Researchers can utilize A 844606 to explore the role of α4β2 nAChR in these disorders and to assess potential therapeutic strategies.

    10 mg
    $335.00
    50 mg
    $1,295.00
    All 3 sizes
  • Anabasine hydrochloride
    Cat. No.
    A67694

    Anabasine hydrochloride

    Synonyms: (S)-Anabasine hydrochloride; (+)-Anabasine hydrochloride

    Anabasine hydrochloride is a potent agonist of nicotinic acetylcholine receptors (nAChRs). This alkaloid, derived from tobacco (Nicotiana), functions as a full agonist, inducing depolarization in TE671 cells that endogenously express human fetal muscle-type nAChRs (EC50 = 0.7 µM). Anabasine hydrochloride is relevant for research applications in neurobiology and toxicology, particularly in studies exploring nAChR signaling and muscle contraction mechanisms.

    50 mg
    $435.00
    All 1 sizes
  • Chlorisondamine
    Cat. No.
    A67695

    Chlorisondamine

    Chlorisondamine is a nicotinic acetylcholine receptor antagonist that functions as a ganglionic blocker. It has been employed in studies to assess neurogenic factors influencing blood pressure and sympathetic vasomotor tone in animal models. Chlorisondamine exhibits antihypertensive properties, with significant effects on blood pressure, cardiac output, and heart rate, notably in murine experimental designs.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • nAChR agonist CMPI hydrochloride
    Cat. No.
    A67696

    nAChR agonist CMPI hydrochloride

    nAChR agonist CMPI hydrochloride is a selective positive allosteric modulator of nicotinic acetylcholine receptors (nAChRs) featuring the α4:α4 subunit interface. It significantly enhances the activity of the (α4)3(β2)2 nAChR in response to acetylcholine, with an EC50 value of 0.26 µM. This compound is valuable for research into nicotine dependence and various neuropsychiatric disorders linked to reduced cholinergic activity in the brain.

    5 mg
    $270.00
    10 mg
    $440.00
    All 2 sizes
  • SEN 78702
    Cat. No.
    A67697

    SEN 78702

    SEN 78702 is an orally active, selective full agonist of the α7 nicotinic acetylcholine receptor (nAChR) with a pEC50 of 6.13. This compound is known to enhance memory functions, making it a valuable tool for research in cognitive disorders. Additionally, SEN 78702 exhibits an acceptable level of hERG inhibition (IC50: 15.8 μM), indicating its potential for further pharmacological investigations.

    Out of stock

    All 3 sizes
  • (R)-Monepantel
    Cat. No.
    A67699

    (R)-Monepantel

    Synonyms: (R)-AAD1566

    (R)-Monepantel is the optical R-enantiomer of monepantel, primarily known for its role in nematode research. This enantiomer does not exhibit nematocidal activity, making it an inactive compound. Its characterization is essential for studies focusing on stereochemistry and the specific biological roles of enantiomers in chemical research.

    1 mg
    $95.00
    5 mg
    $240.00
    All 6 sizes
  • Lobeline
    Cat. No.
    A67700

    Lobeline

    Synonyms: α-Lobeline; L-Lobeline

    Lobeline is a potent nicotinic acetylcholine receptor (nAChR) agonist that effectively penetrates the blood-brain barrier. By inhibiting dopamine (DA) uptake into synaptic vesicles and altering presynaptic DA storage, Lobeline enhances DA release. It is primarily utilized in research focused on addiction and smoking cessation, making it a valuable reagent in the study of dopaminergic signaling pathways.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Varenicline-15N3 Hydrochloride
    Cat. No.
    A67701

    Varenicline-15N3 Hydrochloride

    Synonyms: CP 526555-15N3 Hydrochloride

    Varenicline-15N3 Hydrochloride is the nitrogen-15 labeled isotope of Varenicline hydrochloride, a known partial agonist of the α4β2 nicotinic acetylcholine receptor (α4β2 nAChR) with an IC50 value of 250 nM. It targets nicotine dependence by mitigating the direct agonistic effects of nicotine while providing moderate stimulation of nAChR. Additionally, Varenicline exhibits partial agonist activity at α6β2 nAChR and full agonism at another subset of this receptor. This isotope-labeled compound is valuable for pharmacokinetic studies and research into nicotine addiction and smoking cessation therapies.

    Out of stock

    All 3 sizes
  • (S)-UFR2709
    Cat. No.
    A67702

    (S)-UFR2709

    (S)-UFR2709 is a competitive antagonist of nicotinic acetylcholine receptors (nAChRs), with a notable preference for the α4β2 subtype over α7. This compound exhibits anxiolytic properties, effectively reducing anxiety and lowering ethanol consumption and preference in alcohol-preferring rat models. (S)-UFR2709 serves as a valuable reagent for research into nicotine addiction and related behavioral studies.

    5 mg
    $795.00
    All 1 sizes
  • Cytisine-d4
    Cat. No.
    A67703

    Cytisine-d4

    Cytisine-d4 is a deuterium-labeled derivative of Cytisinicline, an alkaloid known for its role as a partial agonist at α4β2 nicotinic acetylcholine receptors (nAChRs) and for displaying full to partial agonism at β4-containing and α7 receptors. This stable isotope is utilized in research applications aimed at studying receptor interactions and pharmacokinetics, as well as in investigations related to smoking cessation therapies. The incorporation of deuterium allows for enhanced tracking of metabolic pathways and biological activity in various experimental settings.

    Out of stock

    All 3 sizes
  • Epiboxidine
    Cat. No.
    A67705

    Epiboxidine

    Epiboxidine is a potent and selective agonist of neural nicotinic acetylcholine receptors (nAChRs), demonstrating Ki values of 0.46 nM and 1.2 nM for rat and human α4β2 nAChRs, respectively. As a methylisoxazole derivative of the alkaloid Epibatidine, Epiboxidine serves as a valuable tool for studying nAChR-related pathways and their physiological functions. This compound is instrumental in exploring the potential therapeutic applications in neuropharmacology and other related fields.

    Out of stock

    All 3 sizes
  • BMS-902483
    Cat. No.
    A67706

    BMS-902483

    BMS-902483 is a quinuclidine-derived partial agonist of the α7 nicotinic acetylcholine receptor (nAChR). This compound has been shown to enhance cognitive function in preclinical rodent models, making it a valuable tool for investigating cognitive impairment and associated disorders. Its properties make BMS-902483 suitable for research into neuropharmacology and the development of therapeutic strategies for cognitive enhancement.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • nAChR antagonist 3
    Cat. No.
    A67707

    nAChR antagonist 3

    nAChR antagonist 3 is a selective antagonist of the α7 nicotinic acetylcholine receptor, demonstrating an IC50 of 0.86 μM. It exhibits protective effects against toxicity induced by paraoxon, making it a valuable tool for studying organophosphate poisoning. This compound is suitable for research applications focusing on neuroprotection and receptor modulation associated with cholinergic signaling pathways.

    Out of stock

    All 3 sizes
  • Varenicline-d4
    Cat. No.
    A67709

    Varenicline-d4

    Synonyms: CP 526555-d4

    Varenicline-d4 is a deuterium-labeled derivative of Varenicline, a potent partial agonist of the α4β2 nicotinic acetylcholine receptor (nAChR) with an EC50 value of 2.3 μM. Additionally, Varenicline acts as a full agonist at the α3β4 and α7 nAChRs, exhibiting EC50 values of 55 μM and 18 μM, respectively. This stable isotope is instrumental for research involving smoking cessation therapies and the pharmacological investigation of nicotinic receptors.

    0.5 mg
    $175.00
    All 1 sizes
  • nAChR-IN-1 hydrochloride
    Cat. No.
    A67710

    nAChR-IN-1 hydrochloride

    nAChR-IN-1 hydrochloride is a selective nicotinic acetylcholine receptor (nAChR) inhibitor that specifically targets nAChRs lacking the α5, α6, or β3 subunits. This compound is particularly useful in studying the roles of nAChRs in neurological disorders and offers potential insights into therapeutic strategies for conditions involving nicotinic acetylcholine receptor dysfunction. Its effectiveness in modulating nAChR activity makes it a valuable tool for chemical biology and pharmacological research.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Rivanicline fumarate
    Cat. No.
    A67711

    Rivanicline fumarate

    Synonyms: RJR-2403 fumarate; (E)-Metanicotine fumarate

    Rivanicline fumarate is a selective agonist of neuronal nicotinic acetylcholine receptors (nAChRs), primarily targeting the α4β2 subtype with a Ki of 26 nM and an EC50 of 16 μM. This compound has demonstrated the ability to significantly restore learning impairments and alleviate cognitive dysfunctions. Rivanicline fumarate is valuable in research focused on neurodegenerative diseases, including schizophrenia and Alzheimer's disease, providing insights into potential therapeutic approaches.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • (rel)-Asperparaline A
    Cat. No.
    A67712

    (rel)-Asperparaline A

    Synonyms: (rel)-Aspergillimide; (rel)-VM55598

    (rel)-Asperparaline A is a potent antagonist of nicotinic acetylcholine receptors (nAChR), extracted from okara fermented with Aspergillus japonicas JV-23. This compound displays significant paralytic activity in silkworms, highlighting its potential as an anthelmintic agent. Its selectivity and effectiveness make it valuable for research applications focused on neurotransmission and parasitic control.

    1 mg
    $210.00
    5 mg
    $795.00
    All 2 sizes
  • Lupanine hydrochloride
    Cat. No.
    A67713

    Lupanine hydrochloride

    Synonyms: D-Lupanine hydrochloride

    Lupanine hydrochloride is a natural ketonic derivative of Sparteine, functioning as a nicotinic acetylcholine receptor (nAChR) inhibitor. It demonstrates binding affinity for the nAChR with a Ki value of 500 nM, indicating its potential role in modulating cholinergic signaling. This compound is suitable for research applications related to neuromuscular transmission and ganglioplegic activity.

    Out of stock

    All 3 sizes
  • Spinosyn L
    Cat. No.
    A67714

    Spinosyn L

    Spinosyn L is a selective agonist of nicotinic acetylcholine receptors (nAChR). It induces sustained neural excitation and paralysis in insects, demonstrating effective activity against various agricultural pests, including Lepidoptera and Diptera. This compound is valuable for research applications focused on developing novel pesticides and understanding insect physiology.

    5 mg
    $510.00
    10 mg
    $835.00
    All 2 sizes
  • nAChR modulator-2
    Cat. No.
    A67715

    nAChR modulator-2

    nAChR modulator-2 is an orthosteric modulator of insect nicotinic acetylcholine receptors (nAChRs). This compound functions as an effective insecticide by influencing neurotransmission in target insects, leading to neurotoxic effects. It is particularly useful in research applications aimed at understanding insect physiology and the development of novel pest control strategies.

    Out of stock

    All 3 sizes

Items 201-225 of 268

Added to your cart

View Cart Checkout

    Loading...